Splicing factor SC35 promotes tau expression through stabilization of its mRNA

FEBS Letters

Volumn 585, Issue 6, 2011, Pages 875-880

  Qian, Wei ^a,b   Iqbal, Khalid ^b   Grundke Iqbal, Inge ^b   Gong, Cheng Xin ^b   Liu, Fei ^a,b  

^a NANTONG UNIVERSITY   (China)

^b NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

Alzheimer's disease; mRNA stabilization; SC35; Tau

Indexed keywords

MESSENGER RNA; PROTEIN SC35; SERINE ARGININE RICH PROTEIN; TAU PROTEIN; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ARTICLE; BINDING SITE; CONTROLLED STUDY; DOSE RESPONSE; EXON; HUMAN; HUMAN CELL; INTRON; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA PROCESSING; RNA SPLICING; RNA STABILITY; RNA SYNTHESIS; WESTERN BLOTTING;

BLOTTING, WESTERN; EXONS; GENE EXPRESSION; HEK293 CELLS; HUMANS; IMMUNOPRECIPITATION; NUCLEAR PROTEINS; PROTEIN BINDING; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBONUCLEOPROTEINS; RNA STABILITY; RNA, MESSENGER; TAU PROTEINS; TRANSFECTION;

EID: 79952575748     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2011.02.017     Document Type: Article

References (36)

1. Kar, S., Fan, J., Smith, M.J., Goedert, M. and Amos, L.A. (2003) Repeat motifs of tau bind to the insides of microtubules in the absence of taxol. EMBO J. 22, 70-77. (Pubitemid 36091270)
2. Grundke-Iqbal, I., Iqbal, K., Tung, Y.C., Quinlan, M., Wisniewski, H.M. and Binder, L.I. (1986) Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc. Natl. Acad. Sci. USA 83, 4913-4917.
3. Ballatore, C., Lee, V.M. and Trojanowski, J.Q. (2007) Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nat. Rev. Neurosci. 8, 663-672.
4. Grundke-Iqbal, I., Iqbal, K., Quinlan, M., Tung, Y.C., Zaidi, M.S. and Wisniewski, H.M. (1986) Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. J. Biol. Chem. 261, 6084-6089.
5. Iqbal, K. et al. (2005) Tau pathology in Alzheimer disease and other tauopathies. Biochim. Biophys. Acta 1739, 198-210.
6. Khatoon, S., Grundke-Iqbal, I. and Iqbal, K. (1992) Brain levels of microtubule-associated protein tau are elevated in Alzheimer's disease: a radioimmuno-slot-blot assay for nanograms of the protein. J. Neurochem. 59, 750-753.
7. Shi, J. et al. (2008) Increased dosage of Dyrk1A alters alternative splicing factor (ASF)-regulated alternative splicing of tau in Down syndrome. J. Biol. Chem. 283, 28660-28669.
8. Ebneth, A., Godemann, R., Stamer, K., Illenberger, S., Trinczek, B. and Mandelkow, E. (1998) Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: implications for Alzheimer's disease. J. Cell Biol. 143, 777-794. (Pubitemid 28512571)
9. Santacruz, K. et al. (2005) Tau suppression in a neurodegenerative mouse model improves memory function. Science 309, 476-481. (Pubitemid 40994688)
10. Roberson, E.D. et al. (2007) Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model. Science 316, 750-754. (Pubitemid 46717684)
11. Goedert, M., Spillantini, M.G., Jakes, R., Rutherford, D. and Crowther, R.A. (1989) Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 3, 519-526.
12. Andreadis, A., Brown, W.M. and Kosik, K.S. (1992) Structure and novel exons of the human tau gene. Biochemistry 31, 10626-10633.
13. Goedert, M., Spillantini, M.G., Potier, M.C., Ulrich, J. and Crowther, R.A. (1989) Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain. EMBO J. 8, 393-399. (Pubitemid 19274956)
14. Goedert, M. and Jakes, R. (1990) Expression of separate isoforms of human tau protein: correlation with the tau pattern in brain and effects on tubulin polymerization. EMBO J. 9, 4225-4230. (Pubitemid 120025977)
15. Kosik, K.S., Orecchio, L.D., Bakalis, S. and Neve, R.L. (1989) Developmentally regulated expression of specific tau sequences. Neuron 2, 1389-1397.
16. Alvarez, M., Estivill, X. and de la Luna, S. (2003) DYRK1A accumulates in splicing speckles through a novel targeting signal and induces speckle disassembly. J. Cell Sci. 116, 3099-3107. (Pubitemid 37038959)
17. D'Souza, I. and Schellenberg, G.D. (2005) Regulation of tau isoform expression and dementia. Biochim. Biophys. Acta 1739, 104-115.
18. Goedert, M. and Jakes, R. (2005) Mutations causing neurodegenerative tauopathies. Biochim. Biophys. Acta 1739, 240-250.
19. Sergeant, N., Delacourte, A. and Buee, L. (2005) Tau protein as a differential biomarker of tauopathies. Biochim. Biophys. Acta 1739, 179-197.
20. Graveley, B.R. (2000) Sorting out the complexity of SR protein functions. RNA 6, 1197-1211.
21. Zhong, X.Y., Wang, P., Han, J., Rosenfeld, M.G. and Fu, X.D. (2009) SR proteins in vertical integration of gene expression from transcription to RNA processing to translation. Mol. Cell 35, 1-10.
22. Fu, X.D. and Maniatis, T. (1990) Factor required for mammalian spliceosome assembly is localized to discrete regions in the nucleus. Nature 343, 437-441.
23. Fu, X.D. and Maniatis, T. (1992) Isolation of a complementary DNA that encodes the mammalian splicing factor SC35. Science 256, 535-538.
24. Xiao, R., Sun, Y., Ding, J.H., Lin, S., Rose, D.W., Rosenfeld, M.G., Fu, X.D. and Li, X. (2007) Splicing regulator SC35 is essential for genomic stability and cell proliferation during mammalian organogenesis. Mol. Cell. Biol. 27, 5393-5402.
25. Lin, S., Coutinho-Mansfield, G., Wang, D., Pandit, S. and Fu, X.D. (2008) The splicing factor SC35 has an active role in transcriptional elongation. Nat. Struct. Mol. Biol. 15, 819-826.
26. Liu, F., Iqbal, K., Grundke-Iqbal, I., Hart, G.W. and Gong, C.X. (2004) O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease. Proc. Natl. Acad. Sci. USA 101, 10804-10809.
27. Niranjanakumari, S., Lasda, E., Brazas, R. and Garcia-Blanco, M.A. (2002) Reversible cross-linking combined with immunoprecipitation to study RNA- protein interactions in vivo. Methods 26, 182-190. (Pubitemid 34969580)
28. Gilbert, S.L., Pehrson, J.R. and Sharp, P.A. (2000) XIST RNA associates with specific regions of the inactive X chromatin. J. Biol. Chem. 275, 36491-36494.
29. Sun, B.K., Deaton, A.M. and Lee, J.T. (2006) A transient heterochromatic state in Xist preempts X inactivation choice without RNA stabilization. Mol. Cell 21, 617-628. (Pubitemid 43290729)
30. D'Souza, I. and Schellenberg, G.D. (2000) Determinants of 4-repeat tau expression. Coordination between enhancing and inhibitory splicing sequences for exon 10 inclusion. J. Biol. Chem. 275, 17700-17709.
31. Hernandez, F., Perez, M., Lucas, J.J., Mata, A.M., Bhat, R. and Avila, J. (2004) Glycogen synthase kinase-3 plays a crucial role in tau exon 10 splicing and intranuclear distribution of SC35. Implications for Alzheimer's disease. J. Biol. Chem. 279, 3801-3806.
32. Liu, F. and Gong, C.X. (2008) Tau exon 10 alternative splicing and tauopathies. Mol. Neurodegener. 3, 8.
33. Sanford, J.R., Gray, N.K., Beckmann, K. and Caceres, J.F. (2004) A novel role for shuttling SR proteins in mRNA translation. Genes Dev. 18, 755-768. (Pubitemid 38480888)
34. Caceres, J.F., Screaton, G.R. and Krainer, A.R. (1998) A specific subset of SR proteins shuttles continuously between the nucleus and the cytoplasm. Genes Dev. 12, 55-66. (Pubitemid 28083658)
35. Qian, W., Shi, J., Yin, X., Iqbal, K., Grundke-Iqbal, I., Gong, C.X. and Liu, F. (2010) PP2A regulates tau phosphorylation directly and also indirectly via activating GSK-3beta. J. Alzheimers Dis. 19, 1221-1229.
36. Pei, J.J., Braak, E., Braak, H., Grundke-Iqbal, I., Iqbal, K., Winblad, B. and Cowburn, R.F. (1999) Distribution of active glycogen synthase kinase 3beta (GSK-3beta) in brains staged for Alzheimer disease neurofibrillary changes. J. Neuropathol. Exp. Neurol. 58, 1010-1019.